246 related articles for article (PubMed ID: 21470282)
1. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract][Full Text] [Related]
3. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
4. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
[TBL] [Abstract][Full Text] [Related]
5. [A clinical analysis of glucagonoma syndrome (four cases reported)].
Ma DL; Zeng JY; Wang BX; Fang K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):210-3. PubMed ID: 12905724
[TBL] [Abstract][Full Text] [Related]
6. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract][Full Text] [Related]
7. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
Saavedra C; Lamarca A; Hubner RA
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
[TBL] [Abstract][Full Text] [Related]
8. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
[TBL] [Abstract][Full Text] [Related]
9. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
10. Glucagonoma syndrome: a review and update on treatment.
John AM; Schwartz RA
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2016-2022. PubMed ID: 27422767
[TBL] [Abstract][Full Text] [Related]
11. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
12. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
13. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
Chen HW; Chen HW; Su DH; Shun CT; Liu KL
J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
[TBL] [Abstract][Full Text] [Related]
14. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
15. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
[TBL] [Abstract][Full Text] [Related]
16. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
17. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
Wu SL; Bai JG; Xu J; Ma QY; Wu Z
World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CT.
Sahoo MK; Gupta S; Singh I; Pahwa S; Durgapal P; Bal CS
Asia Pac J Clin Oncol; 2014 Jun; 10(2):190-3. PubMed ID: 23279825
[TBL] [Abstract][Full Text] [Related]
19. Glucagonoma syndrome with severe erythematous rash: A rare case report.
Wang ZX; Wang F; Zhao JG
Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
[TBL] [Abstract][Full Text] [Related]
20. [Glucagonoma syndrome without diabetes mellitus].
Mikkelsen CS; Mikkelsen DB; Vestergaard V; Clemmensen O; Nielsen HO; Bygum A
Ugeskr Laeger; 2008 Nov; 170(47):3876. PubMed ID: 19014744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]